{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:43:49Z","timestamp":1788371029420,"version":"build-2803163510"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.neuropharm.2020.107948","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T16:21:43Z","timestamp":1578500503000},"page":"107948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Approaches to develop therapeutics to treat frontotemporal dementia"],"prefix":"10.1016","volume":"166","author":[{"given":"Lisa P.","family":"Elia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Reisine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amela","family":"Alijagic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Finkbeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.107948_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-4-7","article-title":"Progranulin in frontotemporal lobar degeneration and neuroinflammation","volume":"4","author":"Ahmed","year":"2007","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2020.107948_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2353\/ajpath.2010.090915","article-title":"Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging","volume":"177","author":"Ahmed","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib3","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1080\/15548627.2015.1093718","article-title":"GABARAP-mediated targeting of PI4K2A\/PI4KIIalpha to autophagosomes regulates PtdIns4P-dependent autophagosome-lysosome fusion","volume":"11","author":"Albanesi","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2020.107948_bib4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbamcr.2011.08.007","article-title":"TRAP-1, the mitochondrial Hsp90","volume":"1823","author":"Altieri","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2020.107948_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/cdd.2011.128","article-title":"TRAP1 and the proteasome regulatory particle TBP7\/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins","volume":"19","author":"Amoroso","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2020.107948_bib7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/awx060","article-title":"Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia","volume":"140","author":"Arrant","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2020.107948_bib8","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib9","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1600-0854.2000.010307.x","article-title":"Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking","volume":"1","author":"Babst","year":"2000","journal-title":"Traffic"},{"key":"10.1016\/j.neuropharm.2020.107948_bib11","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.107948_bib12","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1074\/jbc.M111.294801","article-title":"A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (Hsp90) client protein","volume":"287","author":"Baldo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.107948_bib13","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1200\/JCO.2005.00.612","article-title":"Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies","volume":"23","author":"Banerji","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12900","article-title":"TRAP1 regulates autophagy in lung cancer cells","volume":"48","author":"Barbosa","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"issue":"15","key":"10.1016\/j.neuropharm.2020.107948_bib15","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/hmg\/ddx162","article-title":"Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo","volume":"26","author":"Beel","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2020.107948_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-018-0288-y","article-title":"Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice","volume":"13","author":"Beel","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2020.107948_bib17","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.215152","article-title":"Autophagy-dependent cell death - where, how and why a cell eats itself to death","volume":"131","author":"Bialik","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib18","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1073\/pnas.1008098108","article-title":"Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1","volume":"108","author":"Boeckel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.107948_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1091\/mbc.e10-06-0553","article-title":"Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane","volume":"22","author":"Bond","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuropharm.2020.107948_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2008.06.021","article-title":"Sortilin mediates the lysosomal targeting of cathepsins D and H","volume":"373","author":"Canuel","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2020.107948_bib21","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1523\/JNEUROSCI.5757-10.2011","article-title":"Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase","volume":"31","author":"Capell","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib22","doi-asserted-by":"crossref","first-page":"25879","DOI":"10.1074\/jbc.M114.560128","article-title":"Progranulin transcripts with short and long 5' untranslated regions (UTRs) are differentially expressed via posttranscriptional and translational repression","volume":"289","author":"Capell","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.107948_bib23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ajhg.2010.11.002","article-title":"Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma","volume":"87","author":"Carrasquillo","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2020.107948_bib24","doi-asserted-by":"crossref","first-page":"32298","DOI":"10.1074\/jbc.R112.399170","article-title":"Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration","volume":"287","author":"Cenik","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.107948_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1126\/science.1145801","article-title":"JMJD6 is a histone arginine demethylase","volume":"318","author":"Chang","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.107948_bib26","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1084\/jem.20160999","article-title":"Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation","volume":"214","author":"Chang","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2020.107948_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00415-014-7630-2","article-title":"Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis","volume":"262","author":"Chen","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-009-0576-2","article-title":"Brain progranulin expression in GRN-associated frontotemporal lobar degeneration","volume":"119","author":"Chen-Plotkin","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1326-5-41","article-title":"Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1","volume":"5","author":"Chitramuthu","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2020.107948_bib30","first-page":"5553","article-title":"Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles","volume":"126","author":"Colombo","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib31","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nature05017","article-title":"Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21","volume":"442","author":"Cruts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.107948_bib32","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1212\/WNL.0000000000004494","article-title":"Sex differences in the prevalence of genetic mutations in FTD and ALS: a meta-analysis","volume":"89","author":"Curtis","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2020.107948_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/B978-0-444-64076-5.00027-2","article-title":"Frontotemporal dementia","volume":"148","author":"Deleon","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib34","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1523\/JNEUROSCI.3498-17.2019","article-title":"Genetic regulation of neuronal progranulin reveals a critical role for the autophagy-lysosome pathway","volume":"39","author":"Elia","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4161\/auto.22501","article-title":"Autophagic dysfunction in a lysosomal storage disorder due to impaired proteolysis","volume":"9","author":"Elrick","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2020.107948_bib36","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1093\/hmg\/dds324","article-title":"Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease","volume":"21","author":"Elrick","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2020.107948_bib37","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.celrep.2017.08.056","article-title":"Lipidomic and transcriptomic basis of lysosomal dysfunction in progranulin deficiency","volume":"20","author":"Evers","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2020.107948_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2019.02.006","article-title":"Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues","volume":"78","author":"Ferrari","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2020.107948_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41467-018-02821-z","article-title":"Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology","volume":"9","author":"Fujita","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2020.107948_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000101848","article-title":"Frontotemporal dementia with tau pathology","volume":"4","author":"Gasparini","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuropharm.2020.107948_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1750-1326-7-33","article-title":"Progranulin regulates neuronal outgrowth independent of sortilin","volume":"7","author":"Gass","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2020.107948_bib42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.brainres.2012.01.075","article-title":"Losing protein in the brain: the case of progranulin","volume":"1476","author":"Ghidoni","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107948_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2011.08.029","article-title":"Core features of frontotemporal dementia recapitulated in progranulin knockout mice","volume":"45","author":"Ghoshal","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2020.107948_bib44","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.2005.09.119","article-title":"Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer","volume":"23","author":"Goetz","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib45","first-page":"845","article-title":"Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis","volume":"127","author":"Gotzl","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-018-0281-5","article-title":"Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice","volume":"13","author":"Gotzl","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2020.107948_bib47","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809711","article-title":"Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism","volume":"11","author":"Gotzl","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2020.107948_bib48","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib49","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.2005.12.085","article-title":"Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors","volume":"23","author":"Grem","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib50","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1128\/MCB.01867-06","article-title":"The ternary complex factor net is downregulated by hypoxia and regulates hypoxia-responsive genes","volume":"27","author":"Gross","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib51","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.onc.1210736","article-title":"The ternary complex factor Net\/Elk-3 participates in the transcriptional response to hypoxia and regulates HIF-1 alpha","volume":"27","author":"Gross","year":"2008","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.neuropharm.2020.107948_bib52","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.neuron.2019.07.002","article-title":"Development of a chimeric model to study and manipulate human microglia in vivo","volume":"103","author":"Hasselmann","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.107948_bib53","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1159\/000487576","article-title":"FOXO1, a potential therapeutic target, regulates autophagic flux, oxidative stress, mitochondrial dysfunction, and apoptosis in human cholangiocarcinoma QBC939 cells","volume":"45","author":"He","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2020.107948_bib54","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1158\/1078-0432.CCR-08-0221","article-title":"A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer","volume":"14","author":"Heath","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2020.107948_bib55","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1093\/nar\/gku488","article-title":"Jumonji domain containing protein 6 (Jmjd6) modulates splicing and specifically interacts with arginine-serine-rich (RS) domains of SR- and SR-like proteins","volume":"42","author":"Heim","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2020.107948_bib56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7150\/ijbs.8095","article-title":"ELK3 suppresses angiogenesis by inhibiting the transcriptional activity of ETS-1 on MT1-MMP","volume":"10","author":"Heo","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ctrv.2012.10.001","article-title":"Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions","volume":"39","author":"Hong","year":"2013","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.neuropharm.2020.107948_bib58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/NEN.0000000000000158","article-title":"Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice","volume":"74","author":"Hosokawa","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib60","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41598-017-01587-6","article-title":"Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation","volume":"7","author":"Hosokawa","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.107948_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1538\/expanim.17-0060","article-title":"Progranulin haploinsufficiency reduces amyloid beta deposition in Alzheimer\u2019s disease model mice","volume":"67","author":"Hosokawa","year":"2018","journal-title":"Exp. Anim."},{"key":"10.1016\/j.neuropharm.2020.107948_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2010.10.009","article-title":"rs5848 polymorphism and serum progranulin level","volume":"300","author":"Hsiung","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib62","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuron.2010.09.034","article-title":"Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin","volume":"68","author":"Hu","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.107948_bib63","doi-asserted-by":"crossref","first-page":"34904","DOI":"10.1038\/srep34904","article-title":"Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons","volume":"6","author":"Imamura","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.107948_bib64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1326-4-16","article-title":"All-you-can-eat: autophagy in neurodegeneration and neuroprotection","volume":"4","author":"Jaeger","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2020.107948_bib65","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.4161\/auto.29745","article-title":"Human GABARAP can restore autophagosome biogenesis in a C. elegans lgg-1 mutant","volume":"10","author":"Jenzer","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2020.107948_bib66","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","article-title":"Staging TDP-43 pathology in Alzheimer's disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-2012-120946","article-title":"GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer's disease patients","volume":"33","author":"Kamalainen","year":"2013","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neuropharm.2020.107948_bib68","doi-asserted-by":"crossref","first-page":"37680","DOI":"10.18632\/oncotarget.8974","article-title":"Phase 1B\/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen","volume":"7","author":"Kong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2020.107948_bib69","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1073\/pnas.1700477114","article-title":"Microglial NFkappaB-TNFalpha hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia","volume":"114","author":"Krabbe","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.107948_bib70","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1523\/JNEUROSCI.0924-09.2009","article-title":"Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia","volume":"29","author":"Lee","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib71","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/me.2014-1266","article-title":"PGRN induces impaired insulin sensitivity and defective autophagy in hepatic insulin resistance","volume":"29","author":"Liu","year":"2015","journal-title":"Mol. Endocrinol."},{"issue":"7","key":"10.1016\/j.neuropharm.2020.107948_bib72","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41388-018-0466-y","article-title":"JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity","volume":"38","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2020.107948_bib73","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","article-title":"Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation","volume":"165","author":"Lui","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2020.107948_bib74","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cbic.201000641","article-title":"The 2-oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues","volume":"12","author":"Mantri","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.neuropharm.2020.107948_bib75","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.201611116","article-title":"No ATG8s, no problem? How LC3\/GABARAP proteins contribute to autophagy","volume":"215","author":"Martens","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib76","first-page":"235","article-title":"New insights into TRAP1 pathway","volume":"2","author":"Matassa","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.neuropharm.2020.107948_bib77","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1021\/jm501107q","article-title":"Design, structure-activity relationship, and in vivo characterization of the development candidate NVP-HSP990","volume":"57","author":"McBride","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.107948_bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.molcel.2014.11.006","article-title":"PLEKHM1 regulates autophagosome-lysosome fusion through HOPS complex and LC3\/GABARAP proteins","volume":"57","author":"McEwan","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2020.107948_bib79","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/1535-7163.MCT-11-0667","article-title":"The novel oral Hsp90 inhibitor NVP-HSP990 exhibits potent and broad-spectrum antitumor activities in vitro and in vivo","volume":"11","author":"Menezes","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neuropharm.2020.107948_bib80","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3672","article-title":"Progranulin protects against amyloid beta deposition and toxicity in Alzheimer's disease mouse models","volume":"20","author":"Minami","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2020.107948_bib81","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1523\/JNEUROSCI.1805-09.2009","article-title":"FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases","volume":"29","author":"Mojsilovic-Petrovic","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/srep21115","article-title":"Progranulin inhibits expression and release of chemokines CXCL9 and CXCL10 in a TNFR1 dependent manner","volume":"6","author":"Mundra","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.107948_bib83","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/mol.110.065714","article-title":"Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db\/db mice","volume":"78","author":"Nagashima","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib84","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.107948_bib85","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1083\/jcb.201607039","article-title":"Atg8 family LC3\/GABARAP proteins are crucial for autophagosome-lysosome fusion but not autophagosome formation during PINK1\/Parkin mitophagy and starvation","volume":"215","author":"Nguyen","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib86","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1038\/ncomms11992","article-title":"Prosaposin is a regulator of progranulin levels and oligomerization","volume":"7","author":"Nicholson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2020.107948_bib87","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1158\/1078-0432.CCR-06-1015","article-title":"A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer","volume":"12","author":"Nowakowski","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2020.107948_bib88","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/hmg\/ddu575","article-title":"Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis","volume":"24","author":"Osaka","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2020.107948_bib89","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbrc.2016.06.057","article-title":"PI3K\/Akt\/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy","volume":"477","author":"Park","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2020.107948_bib90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/path.2580","article-title":"Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models","volume":"219","author":"Pereson","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib91","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/2013.jamaneurol.393","article-title":"Progranulin mutations as risk factors for Alzheimer disease","volume":"70","author":"Perry","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib92","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tins.2014.04.003","article-title":"Progranulin in neurodegenerative disease","volume":"37","author":"Petkau","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib93","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.nbd.2011.10.016","article-title":"Synaptic dysfunction in progranulin-deficient mice","volume":"45","author":"Petkau","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2020.107948_bib94","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2015.12.006","article-title":"Core neuropathological abnormalities in progranulin-deficient mice are penetrant on multiple genetic backgrounds","volume":"315","author":"Petkau","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.107948_bib95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nbd.2017.06.012","article-title":"Conditional loss of progranulin in neurons is not sufficient to cause neuronal ceroid lipofuscinosis-like neuropathology in mice","volume":"106","author":"Petkau","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2020.107948_bib96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12974-017-1000-9","article-title":"Selective depletion of microglial progranulin in mice is not sufficient to cause neuronal ceroid lipofuscinosis or neuroinflammation","volume":"14","author":"Petkau","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2020.107948_bib97","first-page":"5412","article-title":"Activity-dependent secretion of progranulin from synapses","volume":"126","author":"Petoukhov","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2018.02.011","article-title":"Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia","volume":"66","author":"Philtjens","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2020.107948_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087982","article-title":"JMJD6 regulates ERalpha methylation on arginine","volume":"9","author":"Poulard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2020.107948_bib100","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.109.158436","article-title":"Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity","volume":"332","author":"Putcha","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2020.107948_bib101","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/11533100-000000000-00000","article-title":"Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management","volume":"24","author":"Rabinovici","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2020.107948_bib102","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrneurol.2012.117","article-title":"Advances in understanding the molecular basis of frontotemporal dementia","volume":"8","author":"Rademakers","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib103","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1158\/1078-0432.CCR-04-2322","article-title":"Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers","volume":"11","author":"Ramanathan","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2020.107948_bib104","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1158\/1078-0432.CCR-06-2233","article-title":"Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers","volume":"13","author":"Ramanathan","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2020.107948_bib105","first-page":"297","article-title":"J. Frontotemporal lobar degeneration: current perspectives","volume":"10","author":"Riedl","year":"2014","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2020.107948_bib106","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10637-006-9208-z","article-title":"A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma","volume":"24","author":"Ronnen","year":"2006","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.neuropharm.2020.107948_bib107","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.107948_bib108","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ana.21055","article-title":"Early frontotemporal dementia targets neurons unique to apes and humans","volume":"60","author":"Seeley","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib109","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/WAD.0b013e31815c0f14","article-title":"Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution","volume":"21","author":"Seeley","year":"2007","journal-title":"Alzheimers Dis. Assoc. Disord."},{"key":"10.1016\/j.neuropharm.2020.107948_bib110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1755-5949.2012.00295.x","article-title":"Excessive autophagy contributes to neuron death in cerebral ischemia","volume":"18","author":"Shi","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2020.107948_bib111","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2020.107948_bib112","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1158\/1078-0432.CCR-06-1863","article-title":"Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer","volume":"13","author":"Solit","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2020.107948_bib113","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1158\/1078-0432.CCR-08-1002","article-title":"Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma","volume":"14","author":"Solit","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2020.107948_bib114","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/bjc.2014.653","article-title":"A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies","volume":"112","author":"Spreafico","year":"2015","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.neuropharm.2020.107948_bib115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00401-017-1668-z","article-title":"Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network","volume":"133","author":"Takahashi","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib116","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.neuint.2011.02.015","article-title":"Mitochondrial TRAP1 regulates the unfolded protein response in the endoplasmic reticulum","volume":"58","author":"Takemoto","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2020.107948_bib117","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuroscience.2013.06.049","article-title":"Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice","volume":"250","author":"Tanaka","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.107948_bib118","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2012.11.032","article-title":"Exacerbated inflammatory responses related to activated microglia after traumatic brain injury in progranulin-deficient mice","volume":"231","author":"Tanaka","year":"2013","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.neuropharm.2020.107948_bib120","first-page":"969","article-title":"Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes","volume":"26","author":"Tanaka","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2020.107948_bib119","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40478-014-0078-x","article-title":"Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice","volume":"2","author":"Tanaka","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2020.107948_bib121","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ncb2589","article-title":"Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome","volume":"14","author":"Tumbarello","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib122","first-page":"2561","article-title":"Myosin VI and its cargo adaptors - linking endocytosis and autophagy","volume":"126","author":"Tumbarello","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2020.107948_bib123","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1074\/jbc.M112.433284","article-title":"Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6)","volume":"288","author":"Unoki","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.107948_bib124","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3109\/07853890.2012.665471","article-title":"The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum","volume":"44","author":"Van Langenhove","year":"2012","journal-title":"Ann. Med."},{"key":"10.1016\/j.neuropharm.2020.107948_bib125","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib126","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1038\/ncomms11974","article-title":"Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases","volume":"7","author":"Walport","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2020.107948_bib127","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1600-0854.2010.01098.x","article-title":"The emerging role of VHS domain-containing Tom1, Tom1L1 and Tom1L2 in membrane trafficking","volume":"11","author":"Wang","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.neuropharm.2020.107948_bib128","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1073\/pnas.1507263112","article-title":"GABARAPs regulate PI4P-dependent autophagosome:lysosome fusion","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.107948_bib129","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.20140214","article-title":"Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD","volume":"211","author":"Ward","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2020.107948_bib130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5642","article-title":"Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis","volume":"9","author":"Ward","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2020.107948_bib131","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1126\/science.1175865","article-title":"Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing","volume":"325","author":"Webby","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.107948_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112110","article-title":"Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions","volume":"9","author":"Wei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2020.107948_bib133","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/path.4043","article-title":"Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice","volume":"228","author":"Wils","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib134","first-page":"147","article-title":"TDP-43 in aging and Alzheimer's disease - a review","volume":"4","author":"Wilson","year":"2011","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.107948_bib135","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12035-016-9698-4","article-title":"PGRN is associated with late-onset alzheimer\u2019s disease: a case-control replication study and meta-analysis","volume":"54","author":"Xu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib136","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20091568","article-title":"Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice","volume":"207","author":"Yin","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2020.107948_bib137","first-page":"4639","article-title":"Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia","volume":"24","author":"Yin","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2020.107948_bib138","doi-asserted-by":"crossref","first-page":"20273","DOI":"10.1074\/jbc.M115.646554","article-title":"JmjC domain-containing protein 6 (Jmjd6) derepresses the transcriptional repressor transcription factor 7-like 1 (Tcf7l1) and is required for body Axis patterning during Xenopus embryogenesis","volume":"290","author":"Zhang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.107948_bib139","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncb2069","article-title":"Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity","volume":"12","author":"Zhao","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib140","article-title":"C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking","volume":"6","author":"Zheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2020.107948_bib141","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1083\/jcb.201502029","article-title":"Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin","volume":"210","author":"Zhou","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2020.107948_bib142","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jnc.14110","article-title":"The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and C","volume":"143","author":"Zhou","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.107948_bib143","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1038\/ncomms15277","article-title":"Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations","volume":"8","author":"Zhou","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:58:42Z","timestamp":1758437922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820300149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":142,"alternative-id":["S0028390820300149"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107948","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approaches to develop therapeutics to treat frontotemporal dementia","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107948"}}